Americas Committee for Treatment and Research in Multiple Sclerosis

Acronym

Definition

ACTRIMS

Americas Committee for Treatment and Research in Multiple Sclerosis (Canada and US)

References in periodicals archive	?		Acronyms browser	?		Full browser	?
OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, presented positive interim research findings of its Phase I/II clinical trials of Tovaxin(TM), a novel T cell therapeutic vaccine for Multiple Sclerosis on Friday, September 30, 2005, at the 21st European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the 10th Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) congress held in Thessaloniki, Greece. PharmaFrontiers Presents Positive Tovaxin(TM) Research at ... by Business Wire OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that their research of their Phase I/II clinical trials of Tovaxin(TM), a novel T cell therapeutic vaccine for Multiple Sclerosis, has been accepted for presentation at the 21st Congress of the European Committee/10th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis to be held September 28 - October 1, 2005, in Thessaloniki, Greece. PharmaFrontiers to Present Tovaxin(TM) Research at International ... by Business Wire	AMEMR AMEMSO AMEN AMENC AMENCAR AMEND AMENDA AMENO AMENY AMEO AMEP AMEPAC AMEPP AMEPS AMEQ AMER AMERA AMERC AMERD AMERDC AMEREF AMEREM AMERG AMERI AMERIC Americas Committee for Treatment and Research in Multiple Sclerosis AMERIEZ AMERIND AMERIPEX AMERITECH AMERS AMERSA AMES AMESA AMESB AMESD AMESFUG AMESH Ameslan AMESP AMESS AMESSI AMEST AMESU AMESVI AMET AMETA AMETEC AMETEL AMETI AMETIAP	Americans United for Separation of Church and State Americans United to Preserve Marriage Americans United to Protect Social Security Americans United with Israel Americans Well-informed on Automobile Retailing Economics Americans with disabilities Americans with disabilities act Americans with disabilities act Americans with disabilities act Americans with disabilities act Americans with disabilities act Americans with disabilities act Americans with Disabilities Act Accessibility Guidelines Americans with Disabilities Act Amendments Act of 2008 Americans with Disabilities Act Guidelines Americans with Disabilities Act of 1990 Americans with Disabilities Act of 1990 Americans with Disabilities Act of 1990 Americans with Disabilities Act of 1990 Americans with Disabilities Act Working Group Americans with Disabilities Decisions Americanstar Tours Americanus Americanus Americas Americas Americas Account Opening Center Americas Association of Cooperative/Mutual Insurance Societies Americas Best Value Inn Americas Broadband Broadcasting Network Americas Committee for Treatment and Research in Multiple Sclerosis Americas Conference on Wind Engineering Americas Cup Americas Cup Americas Display Engineering and Applications Conference Americas Foreign Asset Control Software Americas Information Sharing Network Americas Lodging Investment Summit LLC Americas Nuclear Energy Symposium Americas PictureTel User Group Americas Project Management Services Americas Region Caribbean Optical-Ring System Americas Region Caribbean Optical-Ring System Americas Sales and Marketing Organization Americas Society Corporate Program Americas Trade and Sustainable Development Forum Americas wang Americas wang Americas Watch Americas' Central Securities Depositories Association Americas' Conference on Information Systems Americas, antiquity and prehistory of the Americas, University of the americium americium americium americium americium Americium nuclear fuel Americium nuclear fuel Americium nuclear fuel

References in periodicals archive

Acronyms browser

Full browser

OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, presented positive interim research findings of its Phase I/II clinical trials of Tovaxin(TM), a novel T cell therapeutic vaccine for Multiple Sclerosis on Friday, September 30, 2005, at the 21st European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the 10th Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) congress held in Thessaloniki, Greece.

PharmaFrontiers Presents Positive Tovaxin(TM) Research at ... by Business Wire

OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that their research of their Phase I/II clinical trials of Tovaxin(TM), a novel T cell therapeutic vaccine for Multiple Sclerosis, has been accepted for presentation at the 21st Congress of the European Committee/10th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis to be held September 28 - October 1, 2005, in Thessaloniki, Greece.

PharmaFrontiers to Present Tovaxin(TM) Research at International ... by Business Wire